Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use

Int J Cardiol. 2008 Jun 6;126(3):e43-6. doi: 10.1016/j.ijcard.2007.01.017. Epub 2007 Apr 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Adrenergic beta-Antagonists / adverse effects
  • Adrenergic beta-Antagonists / therapeutic use
  • Anti-Arrhythmia Agents / administration & dosage
  • Anti-Arrhythmia Agents / adverse effects
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy*
  • Cardiopulmonary Resuscitation
  • Drug Interactions
  • Echocardiography, Doppler
  • Electric Countershock
  • Electrocardiography
  • Female
  • Follow-Up Studies
  • Glaucoma / diagnosis
  • Glaucoma / drug therapy
  • Heart Arrest / chemically induced*
  • Heart Arrest / therapy
  • Humans
  • Middle Aged
  • Ophthalmic Solutions
  • Propafenone / administration & dosage*
  • Propafenone / adverse effects
  • Risk Assessment
  • Severity of Illness Index
  • Timolol / adverse effects*
  • Timolol / therapeutic use
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • Ophthalmic Solutions
  • Propafenone
  • Timolol